unknown
Stage
About
vTv Therapeutics is a late-stage biopharmaceutical company developing oral small molecule drugs to treat diabetes and other chronic diseases, with a lead candidate cadisegliatin aimed at an oral adjunctive therapy for type 1 diabetes.
Explore vTv Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.